Labcorp Holdings Inc. (LH) stock
LHNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/3016% above fair value
$372.46+1.98 (+0.53%)
Close on Nov 16, 2026Market cap $30.24BP/E 30.6Yield 0.77%
Labcorp r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Labcorp
Labcorp has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?